Zepto Portable Reader
Zepto Life’s Reader is designed to be multi-assay compatible, suitable for point-of-care, point-of-need testing. This shoe-box sized instrument is portable and requires minimal training to operate. The fully-automated nature of our tests as well as the fast turnaround time all contribute to Zepto being the perfect solution for bringing clinical accuracy of results to the point-of-care.
The disposable test cartridge uses microfluidics and on-chip bio-surface technologies to detect target antigens, antibodies or genetic code from just a few drops of patient blood samples. The small channels are designed to decrease the assay time and increase assay automation. Minimal sample preparation is required due to the fully-automated nature of Zepto’s assays.
Zepto’s Immunoassay Platform:
Immunoassay is the quantification of targeted analytes based on the specific relationship between antigen and antibodies. Our immunoassay platforms leverage Giant magnetoresistive (GMR) biosensing to detect clinically relevant concentrations of target biomarkers. Amplification of signal is an advantage that improves the sensitivity of Zepto’s Immunoassay tests. Zepto’s automated magneto-immunoassay platform functions to provide high sensitivity, high specificity and short time-to-results.
Zepto’s Molecular Platform:
Molecular-based detection screens, diagnoses, and monitors diseases by detecting select biological markers in target genetic codes. This detection platform has amplification properties of DNA and RNA and thus has a higher sensitivity in comparison to protein-based detection platforms. PCR amplification creates copies of DNA which then binds to the sensors in Zepto’s cartridge. This is when most molecular platforms stop and process the results of binding. Zepto’s molecular platform goes one step further and verifies perfect binding after amplification. This eliminates false-positives and ensures the accuracy of Zepto’s test results.